focus -WSS

focus

author：Wikipedia 2025-08-28 08:47:02 - browse：79126

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： House transparency, PBM reform bill gains bipartisan support

WSS

A rare thyroid diagnosis led to unexpected, all

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Texas Department of Public Safety speaks out on migrant abuse allegations

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Winning ticket for $1 billion Powerball jackpot sold in California

hotspot

focus

focus

Continuity nursing helped my family in our darkest PICU moments

A new House health package & hospitals’ new site

Continuity nursing helped my family in our darkest PICU moments

Judge rejects Trump's request to move Stormy Daniels hush

Novavax promises a turnaround & Lilly roils the obesity market

Texas Department of Public Safety speaks out on migrant abuse allegations

Anesthesiologist group: stop taking Ozempic before surgery

Study identifies new proteins linked to dementia risk 25 years later

ChatGPT in medicine: STAT answers readers' burning questions

The 10 drugs up first for Medicare price negotiation

focus

Driven by the pandemic, applicants flood public health schools

Mass General totes up its waste in a move to tackle climate change

DeSantis talks Trump, trans issues and 'what wokeness is'

Ending racial health disparities hinges on penalties, political will

Why Congress must ban federal programs from using QALYs

How to protect patients from sexual assault

focus

Wikipedia

hotspot

Wikipedia